Endo Operating Income 2006-2019 | ENDP

Endo operating income from 2006 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Endo Annual Operating Income
(Millions of US $)
2019 $91
2018 $-469
2017 $-960
2016 $-3,472
2015 $-933
2014 $326
2013 $517
2012 $-540
2011 $465
2010 $465
2009 $390
2008 $387
2007 $317
2006 $211
2005 $313
Endo Quarterly Operating Income
(Millions of US $)
2019-12-31 $-94
2019-09-30 $129
2019-06-30 $40
2019-03-31 $16
2018-12-31 $-150
2018-09-30 $-13
2018-06-30 $55
2018-03-31 $-361
2017-12-31 $-304
2017-09-30 $-2
2017-06-30 $-587
2017-03-31 $-67
2016-12-31 $-3,295
2016-09-30 $-36
2016-06-30 $-48
2016-03-31 $-93
2015-12-31 $-204
2015-09-30 $-777
2015-06-30 $1
2015-03-31 $46
2014-12-31 $56
2014-09-30 $137
2014-06-30 $111
2014-03-31 $22
2013-12-31 $210
2013-09-30 $142
2013-06-30 $96
2013-03-31 $68
2012-12-31 $-693
2012-09-30 $144
2012-06-30 $70
2012-03-31 $-61
2011-12-31 $70
2011-09-30 $140
2011-06-30 $134
2011-03-31 $121
2010-12-31 $150
2010-09-30 $116
2010-06-30 $94
2010-03-31 $106
2009-12-31 $163
2009-09-30 $84
2009-06-30 $65
2009-03-31 $77
2008-12-31 $113
2008-09-30 $107
2008-06-30 $82
2008-03-31 $85
2007-12-31 $68
2007-09-30 $80
2007-06-30 $86
2007-03-31 $83
2006-12-31 $28
2006-09-30 $66
2006-06-30 $89
2006-03-31 $27
2005-12-31 $111
2005-09-30 $105
2005-06-30 $77
2005-03-31 $20
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.721B $2.914B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.432B 31.49
Takeda Pharmaceutical (TAK) Japan $45.999B 8.06
Astellas Pharma (ALPMY) Japan $27.558B 13.76
Eisai (ESALY) Japan $19.334B 36.02
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $13.187B 16.39
Merck (MKGAF) Germany $12.536B 16.44
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.917B 219.95
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.164B 29.48
Ionis Pharmaceuticals (IONS) United States $6.754B 20.47
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.361B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.544B 6.76
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.597B 0.00
IPSEN SA ADR (IPSEY) France $4.543B 0.00
United Therapeutics (UTHR) United States $4.070B 0.00
Evotec AG (EVTCY) Germany $3.428B 55.29
Hypermarcas (HYPMY) Brazil $3.424B 10.41
Nektar Therapeutics (NKTR) United States $2.994B 0.00
FibroGen (FGEN) United States $2.866B 0.00
PTC Therapeutics (PTCT) United States $2.666B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.655B 49.28
Taro Pharmaceutical Industries (TARO) Israel $2.418B 9.78
ChemoCentryx (CCXI) United States $2.402B 0.00
Xencor (XNCR) United States $1.649B 67.35
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.620B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.561B 18.98
Theravance Biopharma (TBPH) Cayman Islands $1.439B 0.00
Sage Therapeutics (SAGE) United States $1.347B 0.00
USANA Health Sciences (USNA) United States $1.344B 14.11
Corcept Therapeutics (CORT) United States $1.335B 14.94
Pacira Pharmaceuticals (PCRX) United States $1.295B 35.40
Karyopharm Therapeutics (KPTI) United States $1.168B 0.00
Heron Therapeutics (HRTX) United States $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 31.30
Zogenix (ZGNX) United States $1.010B 0.00
Akebia Therapeutics (AKBA) United States $0.874B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.859B 11.96
Esperion Therapeutics (ESPR) United States $0.846B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.781B 0.00
ImmunoGen (IMGN) United States $0.596B 0.00
Tilray (TLRY) Canada $0.576B 0.00
Translate Bio (TBIO) United States $0.572B 0.00
Aerie Pharmaceuticals (AERI) United States $0.565B 0.00
Molecular Templates (MTEM) United States $0.561B 0.00
Collegium Pharmaceutical (COLL) United States $0.553B 0.00
Radius Health (RDUS) United States $0.550B 0.00
Portola Pharmaceuticals (PTLA) United States $0.504B 0.00
Indivior (INVVY) United States $0.397B 2.36
Siga Technologies (SIGA) United States $0.393B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.386B 15.84
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.378B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 12.17
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.324B 0.00
Organogenesis Holdings (ORGO) United States $0.312B 0.00
Trillium Therapeutics (TRIL) Canada $0.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.299B 0.00
Calithera Biosciences (CALA) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.285B 4.58
Harpoon Therapeutics (HARP) United States $0.277B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.263B 0.00
DURECT (DRRX) United States $0.260B 0.00
Flexion Therapeutics (FLXN) United States $0.256B 0.00
Ocular Therapeutix (OCUL) United States $0.251B 0.00
TherapeuticsMD (TXMD) United States $0.250B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.246B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.243B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
Rafael Holdings (RFL) United States $0.186B 0.00
CASI Pharmaceuticals (CASI) United States $0.185B 0.00
Recro Pharma (REPH) United States $0.166B 0.00
OptiNose (OPTN) United States $0.164B 0.00
PROFOUND MEDICL (PROF) Canada $0.157B 0.00
MEI Pharma (MEIP) United States $0.155B 0.00
Jounce Therapeutics (JNCE) United States $0.145B 2.61
Nature's Sunshine Products (NATR) United States $0.140B 17.58
La Jolla Pharmaceutical (LJPC) United States $0.140B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.120B 0.00
Redhill Biopharma (RDHL) Israel $0.104B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
IMV INC (IMV) Canada $0.086B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.081B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.074B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.068B 0.00
Biomerica (BMRA) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Xeris Pharmaceuticals (XERS) United States $0.064B 0.00
Aquestive Therapeutics (AQST) United States $0.062B 0.00
Otonomy (OTIC) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 17.62
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.052B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Aclaris Therapeutics (ACRS) United States $0.046B 0.00
PharmAthene (ALT) United States $0.045B 0.00
GTx (ONCT) United States $0.044B 0.00
Natural Alternatives (NAII) United States $0.043B 19.47
MediWound (MDWD) Israel $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 133.57
Sundial Growers (SNDL) Canada $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Forward Pharma (FWP) Denmark $0.035B 0.00
PolarityTE (PTE) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.021B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Mannatechorporated (MTEX) United States $0.018B 5.78
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Novan (NOVN) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
KemPharm (KMPH) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00